Prolactin receptor expression as a novel prognostic biomarker for triple negative breast cancer patients

Prolactin receptor (PRLR) is a novel emerging prognostic biomarker in different cancers, especially in breast cancer. However, there is limited information about the association of PRLR expression and triple-negative breast cancers (TNBC) prognosis. In this study, 80 TNBC patients were evaluated for...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Annals of diagnostic pathology 2020-06, Vol.46, p.151507-151507, Article 151507
Hauptverfasser:	Motamedi, Behnaz, Rafiee-Pour, Hossain-Ali, Khosravi, Mohammad-Reza, Kefayat, Amirhosein, Baradaran, Azar, Amjadi, Elham, Goli, Parvin
Format:	Artikel
Sprache:	eng
Schlagworte:	Immunohistochemistry Overall survival Prognostic biomarker Prolactin receptor Triple-negative breast cancer
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!